Physical Therapists in Water Valley, MS Accepting Medicare

8 Physical Therapists found. Showing 1 - 8

Andrew C Jeffreys Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 50 S Main St, Water Valley, MS 38965 Phone: 662-473-4777    Fax: 662-473-2233

Cornerstone Rehabilitation, Inc Physical Therapist Medicare: Medicare Enrolled Practice Location: 50 S Main St, Water Valley, MS 38965 Phone: 662-473-4777    Fax: 662-473-2233

Taylor Robertson Faulkner, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 305 N Main St, Water Valley, MS 38965 Phone: 662-714-4472    Fax: 662-714-4463

Tyler Cox, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 305 N Main St, Water Valley, MS 38965 Phone: 662-714-4472    Fax: 662-714-4463

Carrie Aden Mcdaniel, PT, ATC Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 305 N Main St, Water Valley, MS 38965 Phone: 662-714-4472

Mrs. Jennifer S Mcgavock, P.T Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 50 S Main St, Water Valley, MS 38965 Phone: 662-473-4777    Fax: 662-473-2233

Grady Madison Kuykendall Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 630 S Main St, Water Valley, MS 38965 Phone: 662-473-5947

Matt Defrancisco, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 630 S Main St, Water Valley, MS 38965 Phone: 662-473-1411

News Archive

Henry Schein authorizes repurchase of $200M shares of common stock

Henry Schein, Inc., the largest provider of health care products and services to office-based practitioners, today announced that its Board of Directors has authorized the repurchase of up to $200 million of shares of the Company's common stock.

AVI BioPharma's peptide-conjugated PMO chemistry to be discussed at two upcoming scientific meetings

AVI BioPharma, Inc., a developer of RNA-based drugs, today announced that Hong Moulton, Ph.D., Director of Discovery Research, will give oral presentations highlighting improved analogues of AVI's phosphorodiamidate morpholino oligomer (PMO) chemistry at two upcoming scientific meetings.

Eye drops may prevent the onset of glaucoma in African Americans

Eye drops that reduce elevated pressure inside the eye can delay or possibly prevent the onset of glaucoma in African Americans at higher risk for developing the disease, researchers have found.

Kaiser Permanente's 2010 charitable contributions top $35 million

Kaiser Permanente of the Mid-Atlantic States, the area's largest not-for-profit health plan and care provider, announced today that its 2010 charitable contributions topped $35 million. Approximately $25 million was used for direct medical care and insurance coverage for uninsured and underserved residents of Maryland, Virginia, and the District of Columbia, and another $10 million in grants, donations, and sponsorships went to organizations that support the health of the region.

Interim results from Phase 1 study of ENMD-2076 in refractory MM patients presented at ASH 2010

EntreMed, Inc., today announced the presentation of data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor. Data from the Phase 1 studies with ENMD-2076 in patients with multiple myeloma and relapsed or refractory leukemia were presented by EntreMed investigators during poster sessions at the 2010 American Society of Hematology Annual Meeting being held December 4-7 in Orlando, Florida.

Read more Medical News

› Verified 5 days ago